{"id":"NCT02616614","sponsor":"Actavis Inc.","briefTitle":"Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris","officialTitle":"Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Clindamycin 1.2% and Benzoyl Peroxide 3.75% Gel to OnextonÂ® Gel in Subjects With Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-05","primaryCompletion":"2015-10","completion":"2015-11","firstPosted":"2015-11-30","resultsPosted":"2020-05-27","lastUpdate":"2020-05-27"},"enrollment":862,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"Onexton","otherNames":["Clindamycin/benzoyl peroxide gel"]},{"type":"DRUG","name":"Clindamycin/benzoyl peroxide gel","otherNames":["Clindamcyin Phosphate","BPO"]},{"type":"DRUG","name":"Placebo","otherNames":["Vehicle"]}],"arms":[{"label":"Onexton gel","type":"ACTIVE_COMPARATOR"},{"label":"Clindamycin/benzoyl peroxide gel","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects with Acne Vulgaris","primaryOutcome":{"measure":"Percent Change in the Inflammatory (Papules and Pustules) Lesion Counts","timeFrame":"12 weeks","effectByArm":[{"arm":"Generic Clindamycin and Benzoyl Peroxide","deltaMin":-63.81,"sd":36.791},{"arm":"Reference Onexton (Clindamycin and Benzoyl Peroxide)","deltaMin":-67.56,"sd":28.405},{"arm":"Vehicle Gel","deltaMin":-53.78,"sd":40.138}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000","p":"0.0001"},{"comp":"OG001","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":8,"exclusionCount":26},"locations":{"siteCount":17,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":329},"commonTop":["Dry skin","Pruritus","Erythema","Skin burning sensation","Skin irritation"]}}